Medicine News and Research

RSS

Researchers prove iPS cells can help to treat liver diseases

Great excitement greeted the discovery a few years ago that certain cells from mice and humans could be reprogrammed to become inducible pluripotent stem cells (iPS cells), as they hold promise for cell replacement therapy and modeling human disease.

26 Aug 2010

Angeion Corporation 2010 third quarter revenue increases to $7.1 million

Angeion Corporation today reported results for its fiscal third quarter ended July 31, 2010.

26 Aug 2010

Plantain and broccoli fiber help in Crohn’s disease: Study

New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.

25 Aug 2010

Fox Chase Cancer Center to host Philadelphia Chromosome Symposium

In celebration of a seminal discovery in cancer biology, Fox Chase Cancer Center will host the Philadelphia Chromosome Symposium: Past, Present and Future, on September 28, 2010, from 8 a.m. to 7 p.m. at The Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia. The event marks the 50th anniversary of the discovery of the first genetic abnormality associated with cancer, and the first to lead to a targeted therapy for cancer.

25 Aug 2010

CHX reports positive results from final pivotal trial of Prevora antibacterial tooth coating for cavity prevention

CHX Technologies Inc., a private Canadian pharmaceutical company that is developing new treatments for the prevention of dental diseases, today announced successful results in its final controlled pivotal trial of Prevora, its proprietary antibacterial tooth coating for the prevention of cavities. The trial surpassed objectives set by the Food and Drug Administration (FDA) protocol, clearing the way for CHX to start the process of seeking FDA approval for use in the United States.

25 Aug 2010

Bohai Pharmaceuticals launches new corporate website

Bohai Pharmaceuticals Group, Inc., a China-based pharmaceutical company engaged in the production, manufacturing and distribution of Traditional Chinese Medicine (TCM) in China, today announces the launch of a new corporate website for U.S. investors.

25 Aug 2010

Stem cell therapy cures 12-year-old boy with diabetes

Cellonis Biotechnologies, a Beijing and HK-based medical research and application company, has recorded some remarkable results in the treatment of a twelve-year-old boy with diabetes using their stem cell therapy in a Beijing partner hospital. He has completely regained his normal life, enjoying sports and school activities just like every other person his age, and has been free from injections and drugs for more than half a year.

25 Aug 2010

Healthways, MedNetworks to apply science of social network mapping to improve well-being

Healthways, Inc. today announced an exclusive, strategic partnership with MedNetworks, Inc., a company commercializing social network mapping analytics and technology developed by physician, social scientist and Harvard professor Nicholas Christakis, M.D., Ph.D. MedNetworks has an exclusive license from Harvard University to use the Christakis technology in the healthcare sector.

25 Aug 2010

CHCA selects MedQuist to improve clinical documentation workflow

MedQuist Inc., a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow, continues to build partnerships with the nation's top healthcare organizations by developing and implementing solutions that form the backbone of clinical documentation workflow management.

25 Aug 2010

Diarrhea, skin diseases increase among children in flood-affected areas of Pakistan: Survey

World Vision says assessments conducted over the last few days near the towns of Muzaffar Garh and Kot Addo in Punjab paint a bleak picture of the impact of the flooding. The Christian humanitarian organization says its reports from Sukkur in the Sindh Province are equally dire. Contaminated water, cramped living conditions and a lack of sanitation are contributing to a rapid increase in cases of diarrhea and skin diseases in children.

25 Aug 2010

Centocor R&D wins CIO 100 Award for tranSMART data management system

Recombinant Data Corp., a healthcare data warehousing and clinical intelligence solutions provider, today announced that Centocor R&D, Inc., a subsidiary of Johnson & Johnson, won a CIO 100 Award for tranSMART, a research data management system delivered through a partnership with Recombinant that enables drug research and development data sharing across Johnson & Johnson.

25 Aug 2010

Statin therapy reduces cardiovascular disease risk in patients with high sensitivity C-reactive protein

People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein (hsCRP), a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels.

25 Aug 2010

Merivale Medical Imaging adopts IntelePACS Breast Imaging solution

Intelerad® Medical Systems, a leader in medical imaging PACS and workflow solutions, today announced that Merivale Medical Imaging (MMI) is now using the IntelePACS® Breast Imaging solution for reading and reporting of all its screening and diagnostic mammography studies.

25 Aug 2010

U.S. DOE awards Dynasil 7 Phase-II SBIR grants totaling $6.2 million

Dynasil Corporation of America today announced that the U.S. Department of Energy (DOE) has approved seven of its Phase-II SBIR projects for awards, ranging from $750,000 to $1,000,000 each. The awards, totaling $6.2 million, are being made to its wholly owned subsidiary, Radiation Monitoring Devices, Inc, to develop its state of the art nuclear sensors and instruments.

25 Aug 2010

Tranzyme Pharma to present ulimorelin Phase 2 data at NGM Meeting

Tranzyme Pharma announced today that John Wo, MD, Professor of Medicine, Director, Clinical Research, Division of Gastroenterology, Hepatology and Nutrition, University of Louisville, Louisville, KY, will present ulimorelin Phase 2 data at this year's Joint International NGM Meeting on Saturday, August 28, 2010.

25 Aug 2010

HCM patients undergoing transplant can expect reasonable long-term survival rates: Research

Transplant surgery to correct the most common type of genetic heart disease yields similar short-term and potentially greater long-term survival rates as transplant surgery for other heart diseases, according to research reported in Circulation: Heart Failure, an American Heart Association journal.

25 Aug 2010

3Sbio, Isotechnika Pharma sign development and commercialization agreement for voclosporin inhibitor

Isotechnika Pharma Inc., a biopharmaceutical company focused on the discovery and development of immune modulating therapeutics, and 3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the signing of a development and commercialization agreement for voclosporin, a next generation calcineurin inhibitor being developed for use in the prevention of organ rejection following transplantation and the treatment of autoimmune diseases.

25 Aug 2010

Fewer N.C. physicians seeing Medicare patients; Hospitals try to cut Medicare readmissions

"The national health care reform law, which was was designed to provide insurance coverage and access to physicians to more Americans, has no provision to help a group already having difficulty finding doctors to treat them - senior citizens. According to a report from Cigna Government Services, which processes Medicare claims in North Carolina and 17 other states, more than 80 physicians in North Carolina have opted out of Medicare in the past year. That's in addition to the 100 physicians statewide who stopped seeing Medicare patients in 2008, the report states.

25 Aug 2010

Health law continues to be embroiled in politics, though toned down

In a bid to rally support for the health overhaul among doctors, a White House official underscored both sticks and carrots the federal government is offering the health industry, Reuters reports: "Administration officials said the new law will provide doctors with information technology and incentives to improve the care they deliver, but only if they cooperate.

25 Aug 2010

Sheryl Crow Imaging Center opens in Los Angeles

Breast cancer survivor Sheryl Crow and the Pink Lotus Breast Center today announced the grand opening of the Sheryl Crow Imaging Center, a state of the art breast imaging center featuring the latest advancements in digital screening and diagnostic imaging technologies.

25 Aug 2010